2,5-Dimethoxyamphetamine
Chemical compound
2,5-Dimethoxyamphetamine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
2,5-Dimethoxyamphetamine (2,5-DMA) is a psychedelic and stimulant drug of the amphetamine class. It is a structural analog of amphetamine and is closely related to other phenethylamines such as 2,5-dimethoxy-4-methylamphetamine (DOM) and 2,5-dimethoxy-4-iodoamphetamine (DOI).
Chemical structure and properties[edit | edit source]
2,5-Dimethoxyamphetamine is a substituted amphetamine with the chemical formula C11H17NO2. It features a phenyl ring substituted with two methoxy groups at the 2 and 5 positions, and an amino group attached to the alpha carbon of the propyl chain. This structure is responsible for its psychoactive properties.
Pharmacology[edit | edit source]
2,5-DMA acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. It also has some activity at the dopamine and norepinephrine receptors, contributing to its stimulant properties. The exact mechanism of action is not fully understood, but it is known to alter the normal functioning of neurotransmitter systems in the brain.
Effects[edit | edit source]
The effects of 2,5-DMA are similar to those of other psychedelic amphetamines, including altered perception of time and space, visual and auditory hallucinations, and changes in mood and thought processes. The stimulant effects can include increased energy, alertness, and a sense of euphoria. However, the intensity and duration of these effects can vary significantly between individuals.
History and legal status[edit | edit source]
2,5-Dimethoxyamphetamine was first synthesized in the 1930s, but it did not gain significant attention until the 1960s when it was studied for its psychoactive properties. It is not widely used recreationally, and its legal status varies by country. In many places, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use.
Safety and toxicity[edit | edit source]
The safety profile of 2,5-DMA is not well-documented, but it is believed to have a similar risk profile to other psychedelic amphetamines. Potential risks include cardiovascular effects, neurotoxicity, and psychological distress. As with other psychedelics, there is a risk of adverse psychological reactions, particularly in individuals with a predisposition to mental health disorders.
Related compounds[edit | edit source]
2,5-DMA is part of a larger family of psychedelic and stimulant compounds known as the substituted amphetamines. Related compounds include:
- 2,5-Dimethoxy-4-methylamphetamine (DOM)
- 2,5-Dimethoxy-4-iodoamphetamine (DOI)
- 3,4-Methylenedioxyamphetamine (MDA)
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD